Propanc Biopharma, Inc. Contracts & Agreements

293 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Promissory Note dated January 31, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated February 7, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated January 31, 2025
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated February 7, 2025
Propanc Biopharma, Inc.
Biotechnology
2025
Convertible Promissory Note dated December 15, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated December 4, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated December 15, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated December 4, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Loan Agreement with Aggro Investments Pty Ltd dated December 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Convertible Promissory Note dated September 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated September 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated August 2, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated August 2, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Convertible Promissory Note dated June 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated June 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated June 10, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated June 10, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Convertible Promissory Note dated May 22, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated May 22, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Maturity Extension Agreement dated May 10, 2024
Propanc Biopharma, Inc.
Biotechnology
2024
Convertible Promissory Note dated April 12, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated April 12, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note dated March 1, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated March 1, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Convertible Promissory Note dated December 8, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement dated December 8, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Convertible Promissory Note dated November 29, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement dated November 29, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated October 20, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of October 20, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Redeemable Note, dated October 12, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of October 12, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Redeemable Note, dated August 23, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of August 23, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
10% Original Issue Discount Promissory Note, dated August 15, 2023, issued to the August Lender
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
8% Convertible Promissory Note, dated August 16, 2023, issued to the August Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of August 16, 2023, by and between the Company and the August Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
8% Convertible Promissory Note, dated July 19, 2023, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of July 19, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Equity Line Agreement, dated July 20, 2023, by and between the Company and the Investor
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated July 20, 2023, by and between the Company and the Investor
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
8% Convertible Promissory Note, dated June 29, 2023, issued to the June Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Warrant, dated July 5, 2023
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Securities Purchase Agreement, dated as of June 29, 2022, by and between the Company and the June Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
July Loan Agreement, dated July 5, 2023
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Note, dated November 3, 2022, issued to the Investor
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Equity Line Agreement, dated November 3, 2022, by and between the Company and the Investor
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement, dated November 3, 2022, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated November 3, 2022, by and between the Company and the Investor
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Warrant Agreement, dated March 8, 2023, by and between the Company and the Warrant Holder
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
10% Convertible Redeemable Note, dated February 14, 2023, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated February 14, 2023, by and between the Company and ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Amended and Restated Employment Agreement, by and between the Company and James Nathanielsz, dated October 26, 2022
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2022
8% Convertible Promissory Note, dated October 6, 2022, issued by the Company to Red Road Holdings Corporation
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Redeemable Note, dated September 21, 2022, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Redeemable Note, dated August 12, 2022, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
10% Convertible Redeemable Note, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Promissory Note, dated June 30, 2022, issued by the Company to 1800 Diagonal Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, dated May 12, 2022, issued by the Company to 1800 Diagonal Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, dated April 12, 2022, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
10% Convertible Redeemable Note, dated March 29, 2022, issued by the Company to ONE44 Capital LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
8% Convertible Promissory Note, dated March 7, 2022, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
8% Convertible Promissory Note, January 3, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
10% Convertible Promissory Note, dated December 7, 2021, issued by the Company to ONE44 Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
Common Stock Purchase Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021
Stock Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2021
Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated November 30, 2021
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2021
8% Convertible Promissory Note, dated November 26, 2021, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Consultant Agreement by and between the Company and Paul Patrizio, dated October 1, 2021
Propanc Biopharma, Inc.
Biotechnology
NJ
2021
8% Convertible Promissory Note, dated October 21, 2021, issued by the Company to Sixth Street Lending LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
8% Convertible Promissory Note, dated September 22, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
8% Convertible Promissory Note, dated August 19, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021
Propanc Biopharma, Inc.
Biotechnology
2021
8% Convertible Promissory Note, dated March 16, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
8% Convertible Promissory Note, dated January 5, 2021, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger
Propanc Biopharma, Inc.
Biotechnology
2020
Indemnification Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger
Indemnification Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2020
8% Convertible Redeemable Promissory Note, dated December 10, 2020, issued by the Company to GW Holdings Group, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
8% Convertible Promissory Note, dated December 2, 2020, issued by the Company to Geneva Roth Remark Holdings, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of Prefunded Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Form of Series A Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Form of Series B Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Form of Series C Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Form of Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of Registration Rights Agreement
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Form of First Convertible Redeemable Promissory Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of Second Convertible Redeemable Promissory Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of First Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of Second Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Form of Convertible Promissory Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Convertible Redeemable Promissory Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2019
Form of Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Convertible Promissory Note, issued to Auctus Fund LLC on August 30, 2019 and effective as of September 3, 2019
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant for the purchase of up to 450,000 shares of Propanc Biopharma, Inc.s common stock
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant for the purchase of up to 300,000 shares of Propanc Biopharma, Inc.s common stock
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant for the purchase of up to 225,000 shares of Propanc Biopharma, Inc.s common stock
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Securities Purchase Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Registration Rights Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
10% Convertible Note made in favor of Odyssey Capital Funding LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement dated July 30, 2019, by and between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
8% Convertible Promissory Note, dated July 3, 2019, issued by the Company to Power Up Lending Group Ltd
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Employment Agreement, dated as of June 24, 2019, between Propanc PTY LTD and Carlo Campiciano
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2019
Form of Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Pre-Funded Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Placement Agent Warrant
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Securities Purchase Agreement
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Form of Placement Agency Agreement
Agency Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
8% Convertible Promissory Note, dated May 23, 2019, issued by the Company to Redstart Holdings Corp
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement, dated May 23, 2019, by and between the Company and Redstart Holdings Corp
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Amended and Restated Employment Agreement, dated as of May 14, 2019, between the Company and James Nathanielsz
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Amended and Restated Services Agreement, dated as of May 14, 2019, between the Company and Dr. Julian Kenyon
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
2019 Equity Incentive Plan
Bonus & Incentive Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2019
Form of Indemnification Agreement
Indemnification Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2019
Equity Purchase Agreement, dated February 25, 2019, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Registration Rights Agreement, dated February 25, 2019, by and between the Company and the Investor
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
8% Convertible Redeemable Note, dated December 24, 2018, issued by the Company to Eagle Equities, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement, dated December 24, 2018, by and between the Company and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note, dated November 30, 2018, issued by the Company to Eagle Equities, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement, dated November 30, 2018, by and between the Company and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Equity Purchase Agreement, dated October 5, 2018, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Registration Rights Agreement, dated October 5, 2018, by and between the Company and the Investor
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note, dated October 2, 2018, issued by the Company to Eagle Equities, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note, dated October 2, 2018, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Back End Note, dated October 2, 2018, issued by the Company to GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note, dated October 2, 2018, issued by GS Capital Partners, LLC to the Company
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement, dated October 2, 2018, by and between the Company and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement, dated October 2, 2018, by and between the Company and GS Capital Partners, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Amendment No. 2 to Employment Agreement entered into as of September 25, 2017 by and between James Nathanielsz and the Company
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Power Up Lending Group Ltd
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note issued to Power Up Lending Group Ltd
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note issued to Eagle Equities, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Coventry Enterprises, LLC, dated as of June 29, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note of Coventry Enterprises, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
8% Convertible Redeemable Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and GS Capital Partners, LLC, dated as of April 13, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note of GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and GS Capital Partners, LLC, dated as of March 23, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Back End Note of Propanc Biopharma, Inc
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note of GS Capital Partners, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Power Up Lending Group Ltd
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement by and between Propanc Biopharma, Inc. and Eagle Equities, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Note
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
8% Convertible Redeemable Junior Subordinated Note due October 25, 2018 issued to Eagle Equities, LLC, dated November 3, 2017
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
8% Convertible Redeemable Junior Subordinated Back End Note due October 25, 2018 issued to Eagle Equities, LLC, dated November 3, 2017
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Collateralized Secured Promissory Note (Bank End Note) due June 25, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement by and between the Company and Eagle Equities, LLC, dated as of October 25, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Letter Agreement dated September 30, 2017 between Propanc Biopharma, Inc. and Delafield Investments Limited
Investment Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
8% Convertible Redeemable Junior Subordinated Promissory Note due September 12, 2018 issued to GS Capital, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
8% Convertible Redeemable Junior Subordinated Promissory Note (Back End Note) due September 12, 2018 issued to GS Capital, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Amendment No. 2 to Employment Agreement entered into as of September 25, 2017 by and between James Nathanielsz and the Company
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement by and between the Company and GS Capital Partners, LLC, dated as of September 12, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
10%PER ANNUM, JUNIOR SUBORDINATED $310,000 CONVERTIBLE NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
[Signaturepage follows]
Propanc Biopharma, Inc.
Biotechnology
NY
2017
PROPANCBIOPHARMA, INC 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEJULY 24, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
PROPANCBIOPHARMA, INC 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEJULY 24, 2018 BACKEND NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
GSCAPITAL PARTNERS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE BACKEND NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
NY
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
NY
2017
PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMAY 17, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
NY
2017
PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMARCH 1, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
PROPANCHEALTH GROUP CORPORATION 8%CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATED NOTE DUEMARCH 1, 2018 BACKEND NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
SECURITIESPURCHASE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
NY
2017
40 Wall Street | New York, NY | 10005 p. 347 ###-###-#### | f. 646 ###-###-####
Propanc Biopharma, Inc.
Biotechnology
2017
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018
Propanc Biopharma, Inc.
Biotechnology
2017
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017
Propanc Biopharma, Inc.
Biotechnology
2016
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE PROMISSORY NOTE DUE DECEMBER 2, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
PROPANC HEALTH GROUP CORPORATION COMMON STOCK PURCHASE WARRANT
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
JUNIOR SUBORDINATED PROMISSORYNOTE
Propanc Biopharma, Inc.
Biotechnology
NY
2016
PROPANC HEALTH GROUP CORPORATION UNSECUREDJUNIOR SUBORDINATED PROMISSORY NOTE DUE JUNE 1, 2017
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
[PROPANC HEALTH GROUP CORPORATION LETTERHEAD]
Propanc Biopharma, Inc.
Biotechnology
2016
EQUITY FINANCING AGREEMENT
Financing Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
10%PER ANNUM, $250,000 JUNIOR SUBORDINATED CONVERTIBLE NOTE Note#1
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
10%PER ANNUM, $250,000 JUNIOR SUBORDINATED CONVERTIBLE NOTE Note#2
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
[Signaturepage follows.]
Propanc Biopharma, Inc.
Biotechnology
NY
2016
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017
Propanc Biopharma, Inc.
Biotechnology
2016
PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
EAGLE EQUITIES, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
5%ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUEseptember 13, 2017
Debenture Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
ADDITIONAL ISSUANCE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2016
MANUFACTURING SERVICES AGREEMENT
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
QUALITY ASSURANCE AGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2016
COMMON STOCK PURCHASE WARRANT Propanc Health Group Corporation
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
COMMON STOCK PURCHASE WARRANT Propanc Health Group Corporation
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Level2, 555 Riversdale Road, Camberwell, Victoria, 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com
Propanc Biopharma, Inc.
Biotechnology
2016
Level 2, 555 Riversdale Road, Camberwell, Victoria 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com
Propanc Biopharma, Inc.
Biotechnology
2016
AMENDMENTNO. 1 TO EMPLOYMENTAGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2016
EmploymentAgreement
Propanc Biopharma, Inc.
Biotechnology
NV
2016
DirectorAgreement
Propanc Biopharma, Inc.
Biotechnology
NV
2016
Dated 20XX PROPANC and [INSERT NAME] _______________________________________________ SCIENTIFIC ADVISORYBOARD MEMBER AGREEMENT _______________________________________________...
Propanc Biopharma, Inc.
Biotechnology
2016
ADDENDUM
Propanc Biopharma, Inc.
Biotechnology
2016
5%ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUEOctober 28, 2016
Debenture Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
COMMON STOCK PURCHASE WARRANT PROPANCHEALTH GROUP CORP.
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
SECURITY AGREEMENT
Security Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROMISSORY NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
SECURITYAGREEMENT
Propanc Biopharma, Inc.
Biotechnology
2015
CERTIFICATE OF DESIGNATION OF SERIES B PREFERRED STOCK OF PROPANC HEALTH GROUP CORPORATION Pursuant to Section 151 of the Delaware General Corporation Law
Stock Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2015
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 10, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 10, 2016 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 17, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE FEBRUARY 17, 2016 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUPCORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 12, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8%CONVERTIBLE REDEEMABLE NOTE DUE MARCH 12, 2016 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 20, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 20, 2016 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MARCH 4, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
IL
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
IL
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
DEBT SETTLEMENT AGREEMENT
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
DEBT SETTLEMENT AGREEMENT
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 30 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 30, 2015 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
UNION CAPITAL, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29, 2015 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
LG CAPITAL FUNDING, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
PROPANC HEALTH GROUP CORP. 8% CONVERTIBLE REDEEMABLE NOTE DUE MAY 29, 2015 BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
ADAR BAYS, LLC COLLATERALIZED SECURED PROMISSORY NOTE BACK END NOTE
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
SETTLEMENT AGREEMENT AND STIPULATION
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2014
EQUITY PURCHASE AGREEMENT BY AND BETWEEN PROPANC HEALTH GROUP CORPORATION AND SOUTHRIDGE PARTNERS II LP Dated July __, 2014
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Escrow Agreement with Signature Bank
Escrow Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2011
Form of Subscription Agreement
Subscription Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Limited Distributor Deed
Propanc Biopharma, Inc.
Biotechnology
2011
Investment Banking & Listing Agreement between Propanc Health Group Corporation and Churchill and Associates, LLC dated August 3, 2010
Investment Agreements
Propanc Biopharma, Inc.
Biotechnology
GA
2011
Investment Banking & Listing Agreement between Propanc Health Group Corporation and Churchill and Associates, LLC dated September 16, 2010
Investment Agreements
Propanc Biopharma, Inc.
Biotechnology
GA
2011
Termination Letter
Termination Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
EXHIBIT 10.12 UNIVERSITY OF BATH Dated: 18 July 2008 (1) UNIVERSITY OF BATH (2) PROPANC PTY LTD RESEARCH AGREEMENT IN THE DEPARTMENT OF BIOLOGY AND BIOCHEMISTRY RELATING TO...
Propanc Biopharma, Inc.
Biotechnology
2011
MD Employment Agreement Schedule
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
OFFER TO EXCHANGE SHARES OF PROPANC PTY LTD FOR COMMON STOCK OF PROPANC HEALTH GROUP CORPORATION 576 Swan Street Richmond, VIC, 3121, AUSTRALIA Attention: James Nathanielsz, CEO...
Stock Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2011
EXCHANGE OFFER SUBSCRIPTION AGREEMENT NON-U.S. PERSON
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2011